Published in Proc Natl Acad Sci U S A on December 01, 1974
Idiotypic regulation of the immune system by the induction of antibodies against anti-idiotypic antibodies. Proc Natl Acad Sci U S A (1977) 2.48
Idiotype-anti-idiotype regulation. I. Immunization with a levan-binding myeloma protein leads to the appearance of auto-anti-(anti-idiotype) antibodies and to the activation of silent clones. J Exp Med (1981) 2.28
Antibodies to idiotypes of isologous immunoglobulins. J Exp Med (1975) 1.56
Antibody-specific immunoregulation. J Exp Med (1977) 1.48
Suppression by autogenous complementary idiotypes: the priority of the first response. J Exp Med (1976) 1.43
Enhancing antibody: a novel component of the immune response. Proc Natl Acad Sci U S A (1982) 1.36
Recognition of immunoglobulin idiotypes by thymus-derived lymphocytes. Proc Natl Acad Sci U S A (1975) 1.33
Autoregulation of an antibody response via network-induced auto-anti-idiotype. J Exp Med (1979) 1.30
Suppression of tumor rejection by autologous anti-idiotypic immunity. Proc Natl Acad Sci U S A (1980) 1.28
Induction of idiotype-bearing, nuclease-specific helper T cells by in vivo treatment with anti-idiotype. J Exp Med (1981) 1.18
Production of auto-anti-idiotypic antibody during the normal immune response: changes in the auto-anti-idiotypic antibody response and the idiotype repertoire associated with aging. Proc Natl Acad Sci U S A (1980) 1.09
Autoimmune diseases: immunopathology and etiopathogenesis. Am J Pathol (1982) 1.07
Autoregulation of immune responses via idiotype network interactions. Microbiol Rev (1980) 1.01
Suppression of in vitro monoclonal human rheumatoid factor synthesis by antiidiotypic antibody. Target cells and molecular requirements. J Clin Invest (1983) 0.99
Induction of idiotype-specific suppressor T cells with antigen/antibody complexes. J Exp Med (1983) 0.96
Monoclonal ant-idiotypic antibodies reactive with a highly conserved determinant on A/J serum anti-para-azophenylarsonate antibodies. J Exp Med (1981) 0.96
In vitro idiotypic suppression of chronic lymphocytic leukemia lymphocytes secreting monoclonal immunoglobulin M anti-sheep erythrocyte antibody. J Clin Invest (1980) 0.95
Characterization of anti-Fab' antibodies in human sera: identification of soluble immune complexes that contain hidden anti-KLH and blocking anti-immunoglobulins following immunization with keyhole limpet haemocyanin. Clin Exp Immunol (1983) 0.95
Antigen receptors on murine T lymphocytes in contact sensitivity. III. Mechanism of negative feedback regulation by auto-anti-idiotypic antibody. J Exp Med (1982) 0.93
Invertebrate recognition protein cross-reacts with an immunoglobulin idiotype. J Exp Med (1984) 0.90
Presence of plasma cells binding autologous antibody during an immune response. J Exp Med (1979) 0.89
Generation of idiotype-specific T cell help through network perturbation. J Exp Med (1981) 0.88
Idiotypic self binding of a dominant germline idiotype (T15). Autobody activity is affected by antibody valency. J Exp Med (1987) 0.88
Antigen-induced strain-specific autoantiidiotypic antibodies modulate the immune response to dextran B 512. Proc Natl Acad Sci U S A (1979) 0.88
Evidence for a regulatory idiotypic network in the in vivo response to H-2 antigens. J Exp Med (1985) 0.86
The promise of the anti-idiotype concept. Front Oncol (2012) 0.85
Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A. J Clin Invest (1996) 0.82
Anti-thymocyte serum may enhance or suppress the response to the same antigenic determinant. Immunology (1975) 0.80
Tolerance for self IG at the level of the Ly1+ T cell. J Exp Med (1983) 0.78
Histocompatibility antigens and genetic control of the immune response in guinea pigs IV. Specific inhibition of lymphocyte proliferation by auto-anti-idiotypic antibodies. J Exp Med (1977) 0.78
Deregulation of idiotype expression. Induction of tolerance in an anti-idiotypic response. J Exp Med (1982) 0.77
Anti-idiotypic antibody with potential use as an Eimeria tenella sporozoite antigen surrogate for vaccination of chickens against coccidiosis. Infect Immun (1988) 0.76
Simultaneous complementary idiotypic responses: absence of reciprocal regulation. J Exp Med (1978) 0.76
Regulation of serum antibodies induced in syngeneic rats after administration of monoclonal antibody MT10:21. Immunology (1989) 0.75
The Significance of a Common Idiotype (1F7) on Antibodies against Human Immune Deficiency Virus Type 1 and Hepatitis C Virus. Front Oncol (2016) 0.75
Chemical coupling of proteins to agarose. Nature (1967) 10.52
Chromic chloride: a coupling reagent for passive hemagglutination reactions. J Immunol (1967) 7.30
Immunization of normal mouse spleen cell suspensions in vitro. Science (1966) 6.47
Antibody synthesis at the cellular level. Antibody-induced suppression of 7S antibody synthesis. J Exp Med (1966) 4.49
Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline. J Exp Med (1970) 4.49
Affinity labeling of a phosphorylcholine binding mouse myeloma protein. Biochemistry (1972) 4.26
Assignment of direct and facilitated hemolytic plaques in mice to specific immunoglobulin classes. J Immunol (1968) 3.81
The chemical composition of pneumococcal C-polysaccharide. J Biol Chem (1963) 3.38
Specific suppression of the antibody response by antibodies to receptors. Proc Natl Acad Sci U S A (1972) 3.02
Suppression of idiotypic specificities in adult mice by administration of antiidiotypic antibody. J Exp Med (1972) 2.93
Idiotype suppression. I. Influence of the dose and of the effector functions of anti-idiotypic antibody on the production of an idiotype. Eur J Immunol (1974) 2.90
Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody. Science (1972) 2.73
Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins. Proc Natl Acad Sci U S A (1971) 2.17
Studies of idiotypic antibodies. Production and characterization of autoantiidiotypic antisera. J Exp Med (1974) 1.92
Clonal nature of the immune response to phosphorylcholine. I. Specificity, class, and idiotype of phosphorylcholine-binding receptors on lymphoid cells. J Exp Med (1974) 1.85
Specific suppression of immune responses. Science (1973) 1.67
Senescence of an antibody-forming cell clone. Nature (1972) 1.62
Clonal restriction of the immune response to phosphorylcholine. Nature (1974) 1.25
Antireceptor antiserum causes specific inhibition of reactivity to rat histocompatibility antigens. Science (1974) 0.94
Specific suppression of the antibody response by antibodies to receptors. Proc Natl Acad Sci U S A (1972) 3.02
Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody. Science (1972) 2.73
[Virus proteins. IV. Constitution of the coat protein of the fd phage]. Hoppe Seylers Z Physiol Chem (1969) 2.56
Cyclosporin A-binding protein (cyclophilin) of Neurospora crassa. One gene codes for both the cytosolic and mitochondrial forms. J Biol Chem (1988) 2.43
Incidence and frequency or complications and management of Meckel's diverticulum. Surg Gynecol Obstet (1989) 1.98
Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Proc Natl Acad Sci U S A (1991) 1.97
Specific suppression of immune responses. Science (1973) 1.67
Macroglobulin structure: homology of mu and gamma heavy chains of human immunoglobulins. Science (1969) 1.64
Neonatal tolerance induced by antibody against antigen-specific receptor. Science (1974) 1.61
CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int (2007) 1.58
Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation (2001) 1.54
Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay. Rheumatology (Oxford) (2008) 1.49
The response to phosphorylcholine: dissecting an immune response. Transplant Rev (1975) 1.49
Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site. J Immunol (1992) 1.47
Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl (2001) 1.44
Suppression by autogenous complementary idiotypes: the priority of the first response. J Exp Med (1976) 1.43
A human flora-associated rat model of the breast-fed infant gut. J Pediatr Gastroenterol Nutr (2003) 1.43
Three variable-gene pools common to IgM, IgG and IgA immunoglobulins. Nature (1970) 1.41
Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant (1999) 1.40
[Quality assurance in bariatric surgery in Germany--results of the German multicentre trial 2005 and 2006]. Zentralbl Chir (2008) 1.38
PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy. Am J Transplant (2008) 1.34
The aldolase-binding site of the human erythrocyte membrane is at the NH2 terminus of band 3. J Biol Chem (1981) 1.31
Preparation and analysis of seven major, topographically defined fragments of band 3, the predominant transmembrane polypeptide of human erythrocyte membranes. Biochemistry (1978) 1.30
[Sterno-costo-clavicular hyperostosis: a hitherto undescribed entity (author's transl)]. Dtsch Med Wochenschr (1975) 1.28
Import of cytochrome c into mitochondria. Cytochrome c heme lyase. Eur J Biochem (1987) 1.28
Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine. Klin Wochenschr (1982) 1.26
Clonal restriction of the immune response to phosphorylcholine. Nature (1974) 1.25
Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney Int (1986) 1.23
Interaction of cimetidine with metoprolol, propranolol, or atenolol. Lancet (1981) 1.22
Anti-receptor antibody. II. Induction of long-term unresponsiveness in neonatal mice. J Immunol (1975) 1.19
T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant (2000) 1.17
Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int (2001) 1.17
Sternocostoclavicular hyperostosis: painful swelling of the sternum, clavicles, and upper ribs. Report of two new cases. Ann Intern Med (1977) 1.16
Biomaterial-induced sarcoma: A novel model to study preneoplastic change. Am J Pathol (2000) 1.15
The cloven hoof in legal medicine. Int J Legal Med (2001) 1.15
Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant (1997) 1.15
Priapism during regular haemodialysis. Lancet (1974) 1.14
Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int (1995) 1.12
Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest (1987) 1.09
Clonal depletion in neonatal tolerance. Science (1974) 1.08
Immune response to phosphorylcholine. III. Requirement of the Fc portion and equal effectiveness of IgG subclasses in anti-receptor antibody-induced suppression. J Immunol (1977) 1.08
Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am J Kidney Dis (1995) 1.07
B-cell abnormalities in AIDS: stable and clonally-restricted antibody response in HIV-1 infection. Scand J Immunol (1993) 1.06
Idiotypic networks and nature of molecular mimicry: an overview. Methods Enzymol (1989) 1.05
Comparative macrorestriction and RFLP analysis of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. hominissuis isolates from man, pig, and cattle. Vet Microbiol (2006) 1.05
Immune response to phosphorylcholine. IX. Characterization of hybridoma anti-TEPC15 antibodies. J Immunol (1982) 1.04
An immunologic network. Contemp Top Immunobiol (1980) 1.04
Current trends in biocompatibility testing. Proc Inst Mech Eng H (1998) 1.03
Serological evidence for reactivation of EBV infection due to uraemic immunodeficiency. Nephrol Dial Transplant (1997) 1.02
Nitrocellulose-enzyme-linked immunosorbent assay (NC-ELISA) - a sensitive technique for the rapid visual detection of both viral antigens and antibodies. J Virol Methods (1984) 1.00
Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients. Am J Transplant (2007) 1.00
Subtypes of acute postinfectious glomerulonephritis. Synopsis of clinical and pathological features. Clin Nephrol (1982) 1.00
Refractory period, sensory conduction velocity and visual evoked potentials before and after haemodialysis. J Neurol Neurosurg Psychiatry (1981) 0.99
Studies on the regulation of enolases and compartmentation of cytosolic enzymes in Saccharomyces cerevisiae. Biochim Biophys Acta (1987) 0.99
In vivo effects of dialysate flow rate on Kt/V in maintenance hemodialysis patients. Am J Kidney Dis (2000) 0.98
Light chain isotypes selectively associate with heavy chain idiotypes in T-dependent and T-independent dextran-specific precursors. Nature (1981) 0.98
Combined MLST and AFLP typing of Bartonella henselae isolated from cats reveals new sequence types and suggests clonal evolution. Vet Microbiol (2010) 0.98
DNA repair in Proteus mirabilis. VI. Plasmid (R46-) mediated recovery and UV mutagenesis. Mol Gen Genet (1979) 0.98
T cell activation defect in hemodialysis patients: evidence for a role of the B7/CD28 pathway. Kidney Int (1993) 0.97
Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination. Lancet (1989) 0.97
Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level. J Am Soc Nephrol (1998) 0.96
Human monoclonal and polyclonal anti-human immunodeficiency virus-1 antibodies share a common clonotypic specificity. Eur J Immunol (1992) 0.96
Natural mouse and human antibodies bind to a peptide derived from a germline VH chain. Evidence for evolutionary conserved self-binding locus. J Immunol (1990) 0.96
Antibody-dependent cell-mediated cytotoxicity. I. Differentiation from antibody-independent cytotoxicity by "normal" IgG. J Immunol (1974) 0.96
Review article: percutaneous endoscopic gastrostomy in infants and children. Aliment Pharmacol Ther (2010) 0.96
Anti-receptor antibody. I. Isolation and characterization of the immunoglobulin receptor for phosphorylcholine. J Immunol (1975) 0.96
Fine-needle aspiration of 697 palpable breast lesions with histopathologic correlation. Surgery (1997) 0.95
Neonatal short bowel syndrome as a model of intestinal failure: physiological background for enteral feeding. Clin Nutr (2012) 0.94
Atenolol interaction with aspirin, allopurinol, and ampicillin. Clin Pharmacol Ther (1983) 0.94
Cerebral toxicity of penicillins in relation to their hydrophobic character. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.94
Experiences of two centers of bariatric surgery in the treatment of intragastrale band migration after gastric banding-the importance of the German multicenter observational study for quality assurance in obesity surgery 2005 and 2006. Int J Colorectal Dis (2008) 0.94
Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection. AIDS (2000) 0.94
Antigenic variation of neuraminidase of human type A influenza (H3N2) viruses isolated in Berlin (West). Zentralbl Bakteriol Orig A (1975) 0.94
Regulatory idiotypes. T helper cells recognize a shared VH idiotope on phosphorylcholine-specific antibodies. J Exp Med (1982) 0.93
A nationwide survey on bariatric surgery in Germany--results 2005-2007. Obes Surg (2008) 0.93
Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int (1984) 0.93
Generation and specificity of monoclonal anti-idiotypic antibodies against human HIV-specific antibodies. I. Cross-reacting idiotopes are expressed in subpopulations of HIV-infected individuals. J Immunol (1991) 0.93
Sudden death after isobutane sniffing: a report of two forensic cases. Int J Legal Med (2005) 0.93
[Application and significance of macrophage-electrophoretic-mobility-test (MEM) in neurological diseases (author's transl)]. Klin Wochenschr (1974) 0.92
Proof of air embolism after exhumation. Int J Legal Med (1999) 0.92
Late clonal selection and expansion of the TEPC-15 germ-line specificity. J Exp Med (1980) 0.92
Balb/c T cells have the potential to recognize the TEPC 15 prototype antibody and its somatic variants. J Exp Med (1981) 0.92
Chemo-embolization of experimental liver metastases. Part I: distribution of biodegradable microspheres of different sizes in an animal model for the locoregional therapy. Eur J Pharm Biopharm (1998) 0.91
Immune response to phosphorylcholine. VII. Functional evidence for three separate B cell subpopulations responding to TI and TD PC-antigens. J Immunol (1980) 0.91
Immune response to phosphorylcholine. VIII. The response CBA/N mice to PC-LPS. J Immunol (1981) 0.91
Utilization of fine-needle aspiration in the diagnosis of metastatic tumors to the kidney. Diagn Cytopathol (1999) 0.90
High prevalence of hepatitis G virus (HGV) infections in dialysis staff. Nephrol Dial Transplant (1999) 0.90
Anomalous lymphocyte-antigen reaction in relatives of multiple sclerosis patients. A study of a possible genetic factor in the disease. J Neurol (1977) 0.90
Quantitative determination of taxine B in body fluids by LC-MS-MS. Int J Legal Med (2006) 0.90
From cytotoxicity to biocompatibility testing in vitro: cell adhesion molecule expression defines a new set of parameters. J Mater Sci Mater Med (1997) 0.89
[Virology, serology and pathomorphology of the male genitals after natural and experimental infection with IBR-IPV virus]. Dtsch Tierarztl Wochenschr (1972) 0.89
The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients. Kidney Int (2001) 0.89
Transport of the precursor to neurospora ATPase subunit 9 into yeast mitochondria. Implications on the diversity of the transport mechanism. J Biol Chem (1983) 0.89
Results of sleeve gastrectomy-data from a nationwide survey on bariatric surgery in Germany. Obes Surg (2009) 0.89
Clonal dominance: loss and restoration in adoptive transfer. Proc Natl Acad Sci U S A (1978) 0.89
The cell and molecular biological approach to biomaterial research: a perspective. J Mater Sci Mater Med (1997) 0.88
Differential expression of cell adhesion molecules in inflamed appendix: correlation with clinical stage. J Pathol (1998) 0.88
Acute pancreatitis and hyperamylasaemia in pancreatic carcinoma. Pancreas (1987) 0.88
Generation of idiotype-specific T cell help through network perturbation. J Exp Med (1981) 0.88